Single article

DOI: 10.47026/2413-4864-2024-3-34-48
Full article

UDC: 616.12-008.46
BBC: 54.151

Sveklina T.S., Shustov S.B., Kozlov V.A., Kolyubaeva S.N., Kuchmin A.N., Kochergina N.A., Oktysyuk P.D., Konyaev V.V.

Proteomic Differences in Patients with Type 2 Diabetes Mellitus and Chronic Cardiac Insufficiency with Preserved and Reduced Ejection Fraction

Keywords: chronic cardiac insufficiency, ejection fraction, type 2 diabetes mellitus, proteome, proteins, exosomes, mass spectrometry

The search for protein markers of chronic cardiac insufficiency in combination with type 2 diabetes mellitus is an urgent task. The purpose of the study was to determine the phenotype of patients with chronic cardiac insufficiency with preserved or low ejection fraction, including those burdened with type 2 diabetes mellitus, based on the study of the protein blood profile using polyacrylamide gel electrophoresis, densitometry and mass spectrometric identification of proteins. Material and methods. In 48 patients (69.1±3.1 years) with chronic cardiac insufficiency with preserved or low ejection fraction with or without type 2 diabetes mellitus and healthy volunteers, the proteome was examined by various methods (isolation of exosomes by ultracentrifugation followed by the analysis of the serum exosomes' proteome; analysis of tryptic low molecular weight fragments of whole sera of patients by semi-quantitative MALDI mass spectrometry in the presence of an isotopically labelled standard; electrophoretic separation of serum components in polyacrylamide gel followed by densitometry; serum analysis by HPLC-MS/MS methods) in order to determine specific proteins responsible for the development of chronic cardiac insufficiency in patients with type 2 diabetes mellitus. Research results. Our study revealed the presence of inflammatory proteins (fibrinogen beta, haptoglobin, serotransferrin) and liver tissue (alpha-1-antitrypsin, ApoV) in the studied groups, some of which were reduced compared with the control group (ApoV, fibrinogen beta, serotransferrin, alpha-1-antitrypsin) against the background of standard therapy. HPLC-MS/MS using timsTOF Pro demonstrated more promising results. The differences between the comparison groups obtained using the "gel-based" approach (gel electrophoresis in polyacrylamide gel followed by densitometry) were shown for a number of other proteins (compared with the "gel-free" approach, implying only HPLC-MS/MS, without using separation in gel), which can also be explained by limitation of each of the methods: these approaches to the study of the proteome are complementary rather than interchangeable. Conclusions.There are variations in circulating proteins in patients with cardiac insufficiency associated with differences in the pathophysiology of chronic cardiac insufficiency, which are not fully fixed by the current classification based on determining the ejection fraction. High-performance proteomic analysis methods make it possible to more accurately determine the criteria for the phenotypes of chronic cardiac insufficiency with a preserved ejection fraction and, accordingly, the mechanisms of forming the pathogenetic pathways of this condition.

References

  1. Dedov I.I., Shestakova M.V., Mayorov A.Yu. et al. Algoritmy spetsializirovannoy meditsinskoy pomoshchi bol’nym sakharnym diabetom [Standards of Specialized Diabetes Care]. Sakharnyi diabet, 2023, vol. 26, no. 2S, pp. 1–157.
  2. Teplyakov A.T., Shilov S.N., Berezikova E.N. et all. Kliniko-geneticheskie determinanty genov FNO-os, IL-1/3 i IL-1Ra v initsiatsii i razvitii khronicheskoi serdechnoi nedostatochnosti u bol’nykh ishemicheskoi bolezn’yu serdtsa [Clinical-genetic determinants of TNF, IL-1B and IL-1RA genes in the initiation and development of chronic heart failure in coronary artery disease patients]. Sibirskii zhurnal klinicheskoi i eksperimental’noi meditsiny, 2009, vol. 24, no. 1, pp. 40–48.
  3. Naryzhnyĭ S.N., Legina O.K. Gaptoglobin kak biomarker [Haptoglobin as a biomarker]. Biomeditsinskaya Khimiya, 2021, vol. 67, no. 2, pp.105–1
  4. Mareev V.Yu., Fomin I.V., Ageev F.T. et all. Serdechnaya nedostatochnost’: khronicheskaya (KhSN) i ostraya dekompensirovannaya (ODSN). Diagnostika, profilaktika i lechenie [Russian Scientific Medical Society of Internal Medicine Guidelines for Heart failure: chronic (CHF) and acute decompensated (ADHF)]. Kardiologiya, 2018, vol. 58, no. 6S, pp. 8–158.
  5. Tereshchenko S.N., Galyavich A.S., Uskach T.M. et al. Khronicheskaya serdechnaya nedostatochnost’. Klinicheskie rekomendatsii 2020 [Russian Society of Cardiology (RSC) 2020 Clinical practice guidelines for Chronic heart failure]. Rossiĭskiĭ kardiologicheskiĭ zhurnal, 2020, vol. 25, no. 11, p.
  6. Podzolkov V.I., Dragomiretskaya N.A., Beliaev I.G. et al. Endotelial’naya mikrososudistaya disfunktsiya i yeye vzaimosvyaz’ s urovnem gaptoglobina u patsiyentov s razlichnymi fenotipami khronicheskoy serdechnoy nedostatochnosti [Endothelial Microvascular Dysfunction and Its Relationship with Haptoglobin Levels in Patients with Different Phenotypes of Chronic Heart Failure]. Ratsional’naya farmakoterapiya v kardiologii, 2021, vol. 17, no. 5, pp. 674–682. DOI:10.20996/1819-6446-2021-10-05.
  7. Andrzejczyk K., Abou Kamar S., van Ommen A.M. et al. Identifying plasma proteomic signatures from health to heart failure, across the ejection fraction spectrum. Sci Rep, 2024, vol. 14(1), p. 14871. DOI: 10.1038/s41598-024-65667-0.
  8. Baggerman G., Vierstraete E., De Loof A. et al. Gel-based versus gel-free proteomics: a review. Comb Chem High Throughput Screen, 2005, vol. 8(8), pp. 669–677. DOI: 10.2174/138620705774962490.
  9. Blighe K., Rana S., Lewis M. EnhancedVolcano: publication-ready volcano plots with enhanced colouring and labeling. R package version, 2024, 1.22.0. Available at: https://github.com/kevinblighe/EnhancedVolcano.
  10. Bolstad B.M., Irizarry R.A., Astrand M.A. et al. A comparison of normalization methods for high density oligonucleotide array data based on variance and bias. Bioinformatics, 2003, vol. 19, pp. 185–193.
  11. Carithers L.J., Ardlie K., Barcus M. et al. A Novel Approach to High-Quality Postmortem Tissue Procurement: The GTEx Project. Biopreserv Biobank, 2015, vol. 13(5), pp. 311–319. DOI: 10.1089/2015.0032.
  12. Chen H., Boutros P.C. VennDiagram: a package for the generation of highly-customizable Venn and Euler diagrams in R. BMC Bioinformatics, 2011, vol. 12(35). DOI: 10.1186/1471-2105-12-35.
  13. Engström G., Hedblad B., Tydén P. et al. Inflammation-sensitive plasma proteins are associated with increased incidence of heart failure: a population-based cohort study. Atherosclerosis, 2009, vol. 202(2), pp. 617–22. DOI: 10.1016/j.atherosclerosis.2008.05.038.
  14. Ference B.A., Kastelein JJ.P., Catapano A.L. Lipids and lipoproteins in 2020. JAMA, 2020, vol. 324(6), pp. 595–596.
  15. Fernandes D.C., Araujo TL.S., Laurindo F.R. et al. Endocrine function and metabolic interaction. In: Lilly LS, ed. Pathophysiology of Heart Disease. 6th Baltimore, MD: Wolters Kluwer/Lippincott Williams & Wilkins, 2011, pp. 85–92.
  16. González A., Ravassa S., Beaumont J. et al. New targets to treat the structural remodeling of the myocardium. J Am Coll Cardiol., 2011, vol. 58(18), pp. 1833–1843. DOI: 10.1016/j.jacc.2011.06.058.
  17. Haas B., Serchi T., Wagner D.R. et al. Proteomic analysis of plasma samples from patients with acute myocardial infarction identifies haptoglobin as a potential prognostic biomarker. Journal of Proteomics, 2011, vol. 75(1), pp. 229–36. DOI:10.1016/j.jprot.2011.06.028.
  18. Hastie T., Tibshirani R., Narasimhan B. et al. Impute: Imputation for microarray data. Available at: https://www.bioconductor.org/packages/release/bioc/manuals/impute/man/impute.pdf.
  19. Kim Y.I., Cho J.Y. Gel-based proteomics in disease research: Is it still valuable? Biochim Biophys Acta Proteins Proteom, 2019, vol. 1867(1), pp. 9–16. DOI: 10.1016/j.bbapap.2018.08.001.
  20. Lee J., Park J., Lim M. et al. Quantile normalization approach for liquid chromatography-mass spectrometry-based metabolomic data from healthy human volunteers. Analytical Sciences, 2012, vol. 28(8), pp. 801–805.
  21. Lotvall J., Hill A.F., Hochberg F. et al. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles, 2014, vol. 3, 26913. DOI: 10.3402/jev.v3.26913.
  22. Lu D.Y., Lin C.P., Wu C.H. et al. Plasma haptoglobin level can augment NT-proBNP to predict poor outcome in patients with severe acute decompensated heart failure. J Investig Med, 2019, vol. 67(1), pp. 20–27. DOI: 10.1136/jim-2018-000710.
  23. Mamontova T., Afonin A.M., Ihling Ch. et al. Profiling of seed proteome in pea (Pisum sativum L.) lines characterized with high and low responsivity to combined inoculation with nodule bacteria and arbuscular mycorrhizal fungi. Molecules, 2019, vol. 24(8), 1603.
  24. Meier F., Brunner A.D., Koch S. et al. Online Parallel Accumulation-Serial Fragmentation (PASEF) with a Novel Trapped Ion Mobility Mass Spectrometer. Mol Cell Proteomics, 2018, vol. 17(12), p. 2534–2545. DOI: 10.1074/mcp.TIR118.000900.
  25. Moreira-Costa L., Barros A.S., Lourenço A.P. et al. Exosome-Derived Mediators as Potential Biomarkers for Cardiovascular Diseases: A Network Approach. Proteomes, 2021, vol. 9(1), p. 8. DOI: 10.3390/proteomes9010008.
  26. Paulus W.J., Tschöpe C. A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation. J Am Coll Cardiol., 2013, vol. 62(4), pp. 263– DOI: 10.1016/j.jacc.2013.02.092.
  27. Rappsilber J., Mann M., Ishihama Y. Protocol for micro-purification, enrichment, pre-fractionation and storage of peptides for proteomics using StageTips. Nature Protocols, 2007, vol. 2(8), pp.1896–1906.
  28. Ritchie M.E., Phipson B., Wu D. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Research, 2015, vol. 43(7), e47.
  29. Rohart F., Gautier B., Singh A. et al. MixOmics: An R package for ‘omics feature selection and multiple data integration. PLoS Computational Biology, 2017, vol. 13(11), e1005752.
  30. Schäfer R. Ultraflextreme: redefining MALDI-TOF-TOF-mass spectrometry performance. LC GC Eur. (Suppl. S), 2009, pp. 26–27.
  31. Schwinger R.H.G. Pathophysiology of heart failure. Cardiovasc Diagn Ther, 2021, vol. 11(1), pp. 263–276. DOI: 10.21037/cdt-20-302.
  32. Sebastião M.J., Almeida H.V., Serra M. et al. Unveiling Human Proteome Signatures of Heart Failure with Preserved Ejection Fraction. Biomedicines, 2022, vol. 10(11), 2943. DOI: 10.3390/biomedicines10112943.
  33. Shapiro M.D., Fazio S. Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease. F1000Res, 2017, vol. 6, p. 134.
  34. Troyanskaya O., Cantor M., Sherlock G. et al. Missing value estimation methods for DNA microarrays. Bioinformatics, 2001, vol. 17, pp. 520–525.
  35. Wickham H. Ggplot2: elegant graphics for data analysis. Springer-Verlag, 2016.
  36. Xue R., Tan W., Wu Y. et al. Role of Exosomal miRNAs in Heart Failure. Front Cardiovasc Med, 2020, vol. 7, 592412. DOI: 10.3389/fcvm.2020.592412.

About authors

Sveklina Tatiana S.
Candidate of Medical Sciences, Associate Professor, Department of Internal Diseases Propadeutics, Kirov Military Medical Academy, Russia, St. Petersburg (Sveklinats@mail.ru; ORCID: https://orcid.org/0000-0001-9546-7049)
Shustov Sergey B.
Doctor of Medical Sciences, Professor, 1st Department of Therapy (Advanced Medical Training), Kirov Military Medical Academy, Russia, St. Petersburg (sbs5555@mail.ru; ORCID: https://orcid.org/0000-0002-9075-8274)
Kozlov Vadim A.
Doctor of Biological Sciences, Candidate of Medical Sciences, Professor, Department of Medical Biology with course of Microbiology and Virology, Chuvash State University; Leading Researcher, Postgraduate Doctors' Training Institute, Russia, Cheboksary (pooh12@yandex.ru; ORCID: https://orcid.org/0000-0001-7488-1240)
Kolyubaeva Svetlana N.
Doctor of Biological Sciences, Senior Researcher, Department of Biomedical Research, Research Center, Kirov Military Medical Academy, Russia, St. Petersburg (ksnwma@mail.ru; ORCID: https://orcid.org/0000-0003-2441-9394)
Kuchmin Alexey N.
Doctor of Medical Sciences, Professor, Department of Propedeutics of Internal Diseases, Kirov Military Medical Academy, Russia, St. Petersburg (kuchmin.63@mail.ru; ORCID: https://orcid.org/0000-0003-2888-9625)
Kochergina Natalia A.
Specialist, Center for Collective Use of Equipment "Khromas", Russia, St. Petersburg (st089566@student.spbu.ru; ORCID: https://orcid.org/0009-0005-5919-8570)
Oktysyuk Polina D.
1st year Resident, Department of Internal Medicine Propaedeutics, Kirov Military Medical Academy, Russia, St. Petersburg (polinaok99@gmail.com; ORCID: https://orcid.org/0000-0003-1956-2110)
Konyaev Vladislav V.
1st year Resident, Department of Internal Medicine Propaedeutics, Kirov Military Medical Academy, Russia, St. Petersburg (konyaevvladislav@yandex.ru; ORCID: https://orcid.org/0000-0002-8347-2286)

Article link

Sveklina T.S., Shustov S.B., Kozlov V.A., Kolyubaeva S.N., Kuchmin A.N., Kochergina N.A., Oktysyuk P.D., Konyaev V.V. Proteomic Differences in Patients with Type 2 Diabetes Mellitus and Chronic Cardiac Insufficiency with Preserved and Reduced Ejection Fraction [Electronic resource] // Acta medica Eurasica. – 2024. – №3. P. 34-48. – URL: https://acta-medica-eurasica.ru/en/single/2024/3/5/. DOI: 10.47026/2413-4864-2024-3-34-48.

Menu

Journal numbers

Archive for year 2024
Archive for year 2023
Archive for year 2022
Archive for year 2021
Archive for year 2020
Archive for year 2019
Archive for year 2018
Archive for year 2017
Archive for year 2016
Archive for year 2015